The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2 study of TSN222, a novel dual action tumor immune agonist (DATIA), in patients with advanced malignancies.
 
Wenxing Qin
No Relationships to Disclose
 
Jian Zhang
No Relationships to Disclose
 
Wantao Chen
No Relationships to Disclose
 
Sihua Wang
No Relationships to Disclose
 
Rongrong Li
No Relationships to Disclose
 
Ruiguang Zhang
No Relationships to Disclose
 
Jing Li
Employment - Tyligand Bioscience
 
Baorong Song
Employment - Tyligand Bioscience (Shanghai) Limited
 
Qianxiang Zhou
Employment - Tyligand Bioscience
 
Chunlan Dong
Employment - Tyligand Bioscience
 
Liangbao Lai
Employment - Tyligand Bioscience
 
Shengtang Ma
Employment - Tyligand Bioscience
 
Yanliang Zhang
Employment - Tyligand Bioscience
 
Tony Zhang
Employment - Tyligand Bioscience